Eva Diagnostics: “We identified the pain points of the Blood testing market” #LBRefresh

15/06/2016 - 2 minutes

Eva Diagnostics was one of the contestants at our Startup Battle during Labiotech Refresh. Take a second look with us at the pitch of Eva’s exciting diagnostic Tech…

We had Sabine Dziemian, the head of data analysis at Eva Diagnostics, explain how this spin-off out of Imperial College London is joining the race for MedTech diagnostics.

Please accept preferences cookies to watch this video.

 

Eva Diagnostics was one of our picks for awesome London-based Biotechs and was also featured in the BioBeat15 report for women transforming the UK Biotech scene

eva_diagnostics_labiotech_refresh_blood_countIt has two devices in the making: AnemiPoint, a finger-prick test for anemia, and HemiStat, which could help chemotherapy patients monitor their health, schedule next treatments and detect infections.

Blood-based diagnostics are huge right now. There are many new diagnostics from blood samples coming up, thanks to research on biomarkers – in indications like colorectal cancer,

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

You might also be interested in the following:


Support Us

Become a Member